Instrument Inactif

Autres langues Sapporo Clinical Laboratory Inc.

Actions

9776

JP3321100004

Services d'assistance aux entreprises

Autres langues

07/11	Sapporo Clinical Laboratory Inc - to retire treasury shares worth 26% of outstanding stock on February 17
27/03/24	Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on February 26, 2024.
26/03/24	Sapporo Clinical Laboratory Inc.'s Equity Buyback announced on March 26, 2024, has closed with 210,800 shares, representing 6.33% for ¥189.93 million.
26/02/24	Sapporo Clinical Laboratory Inc. announces an Equity Buyback for 232,100 shares, representing 6.97% for ¥209.12 million.
26/02/24	Sapporo Clinical Laboratory Inc. authorizes a Buyback Plan.
12/05/23	Sapporo Clinical Laboratory Inc. Reports Earnings Results for the Full Year Ended March 31, 2023
31/05/22	Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on May 30, 2022.
31/05/22	Sapporo Clinical Laboratory Inc.'s Equity Buyback announced on May 30, 2022 has closed with 22,700 shares, representing 0.67% for ¥29.21 million.
30/05/22	Sapporo Clinical Laboratory Inc. announces an Equity Buyback for 22,700 shares, representing 0.68% for ¥29.21 million.
30/05/22	Sapporo Clinical Laboratory Inc. authorizes a Buyback Plan.
01/03/22	Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on February 28, 2022.
01/03/22	Sapporo Clinical Laboratory Inc.'s Equity Buyback announced on February 28, 2022, has closed with 53,700 shares, representing 1.58% for ¥69.11 million.
28/02/22	Sapporo Clinical Laboratory Inc. announces an Equity Buyback for 53,700 shares, representing 1.58% for ¥69.11 million.
28/02/22	Sapporo Clinical Laboratory Inc. authorizes a Buyback Plan.
22/06/21	Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on June 21, 2021.
22/06/21	Sapporo Clinical Laboratory Inc.'s Equity Buyback announced on June 21, 2021, has closed with 16,300 shares, representing 0.48% for ¥25.92 million.
21/06/21	Sapporo Clinical Laboratory Inc. announces an Equity Buyback for 16,300 shares, representing 0.48% for ¥25.92 million.
21/06/21	Sapporo Clinical Laboratory Inc. authorizes a Buyback Plan.
27/06/18	Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on June 26, 2018.
27/06/18	Sapporo Clinical Laboratory Inc.'s Equity Buyback announced on June 26, 2018 has expired with 39,200 shares, representing 1.13% for ¥96 million.
26/06/18	Sapporo Clinical Laboratory Inc. announces an Equity Buyback for 45,000 shares, representing 1.3% for ¥110.21 million.
26/06/18	Sapporo Clinical Laboratory Inc. authorizes a Buyback Plan.
27/02/18	Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on February 26, 2018.
27/02/18	Sapporo Clinical Laboratory Inc.'s Equity Buyback announced on February 26, 2018 has expired with 16,800 shares for ¥32.26 million.
26/02/18	Sapporo Clinical Laboratory Inc. announces an Equity Buyback for 20,000 shares, representing 0.57% for ¥38.4 million.